+

PT3826686T - Soluções estáveis de complexo de radionuclídeo concentrado - Google Patents

Soluções estáveis de complexo de radionuclídeo concentrado

Info

Publication number
PT3826686T
PT3826686T PT187831367T PT18783136T PT3826686T PT 3826686 T PT3826686 T PT 3826686T PT 187831367 T PT187831367 T PT 187831367T PT 18783136 T PT18783136 T PT 18783136T PT 3826686 T PT3826686 T PT 3826686T
Authority
PT
Portugal
Prior art keywords
stable
complex solutions
radionuclide complex
concentrated
concentrated radionuclide
Prior art date
Application number
PT187831367T
Other languages
English (en)
Original Assignee
Advanced Accelerator Applications S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/045,484 external-priority patent/US20200030465A1/en
Priority claimed from PCT/IB2018/055575 external-priority patent/WO2020021310A1/en
Application filed by Advanced Accelerator Applications S A filed Critical Advanced Accelerator Applications S A
Publication of PT3826686T publication Critical patent/PT3826686T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121Solutions, i.e. homogeneous liquid formulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PT187831367T 2018-07-25 2018-09-25 Soluções estáveis de complexo de radionuclídeo concentrado PT3826686T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/045,484 US20200030465A1 (en) 2018-07-25 2018-07-25 Stable, concentrated radionuclide complex solutions
PCT/IB2018/055575 WO2020021310A1 (en) 2018-07-25 2018-07-25 Stable, concentrated radionuclide complex solutions

Publications (1)

Publication Number Publication Date
PT3826686T true PT3826686T (pt) 2025-08-04

Family

ID=63794577

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187831367T PT3826686T (pt) 2018-07-25 2018-09-25 Soluções estáveis de complexo de radionuclídeo concentrado

Country Status (21)

Country Link
EP (6) EP3826686B1 (pt)
JP (3) JP7402218B2 (pt)
KR (3) KR102865113B1 (pt)
CN (1) CN112584875A (pt)
AU (6) AU2018433575B2 (pt)
BR (1) BR112021001148A2 (pt)
CA (1) CA3153630A1 (pt)
CO (1) CO2021000506A2 (pt)
DE (1) DE202018006567U1 (pt)
DK (1) DK3826686T3 (pt)
FI (1) FI3826686T3 (pt)
HR (1) HRP20250912T1 (pt)
IL (4) IL319542A (pt)
LT (1) LT3826686T (pt)
MX (1) MX2021000805A (pt)
PL (1) PL3826686T3 (pt)
PT (1) PT3826686T (pt)
RS (1) RS67034B1 (pt)
SG (1) SG11202100645XA (pt)
SI (1) SI3826686T1 (pt)
WO (1) WO2020021322A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11541134B1 (en) 2021-08-02 2023-01-03 Rayzebio, Inc. Stabilized compositions of radionuclides and uses thereof
US20250032652A1 (en) * 2021-11-30 2025-01-30 Nihon Medi-Physics Co., Ltd. Stabilized radiopharmaceutical composition
KR20240146015A (ko) * 2022-02-04 2024-10-07 어드밴스드 엑셀러레이터 어플리케이션즈 방사성 핵종 복합체의 대규모 합성 방법
CN114404618A (zh) * 2022-03-28 2022-04-29 北京先通国际医药科技股份有限公司 放射性药物水溶液及其用途
CN114404619A (zh) * 2022-03-28 2022-04-29 北京先通国际医药科技股份有限公司 放射性药物水溶液及其制备方法和用途
CN116920129A (zh) * 2022-04-02 2023-10-24 北京先通国际医药科技股份有限公司 放射性药物水溶液及其制备方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2779780A (en) 1955-03-01 1957-01-29 Du Pont 1, 4-diamino-2, 3-dicyano-1, 4-bis (substituted mercapto) butadienes and their preparation
US4261989A (en) 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
EP0647450A1 (en) 1993-09-09 1995-04-12 BEHRINGWERKE Aktiengesellschaft Improved prodrugs for enzyme mediated activation
US6066309A (en) * 1996-02-02 2000-05-23 Rhomed Incorporated Post-labeling stabilization of radiolabeled proteins and peptides
WO2000035436A2 (en) 1998-12-16 2000-06-22 Warner-Lambert Company Treatment of arthritis with mek inhibitors
YU2503A (sh) 2000-07-19 2006-05-25 Warner-Lambert Company Oksigenovani estri 4-jodo fenilamino benzhidroksamskih kiselina
US6995162B2 (en) 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
DK1478648T3 (da) 2002-02-01 2014-07-28 Ariad Pharma Inc Phosphorholdige forbindelser og anvendelser deraf
CA2478065C (en) 2002-03-08 2013-01-08 Eisai Co. Ltd. Macrocyclic compounds useful as pharmaceuticals
DOP2003000613A (es) 2002-03-13 2003-09-30 Array Biopharma Inc Derivados de bencimidazol n3 alquilado como inhibidores de mek (n3 alkylated benzimidazole derivatives as mek inhibitors)
TWI275390B (en) 2002-04-30 2007-03-11 Wyeth Corp Process for the preparation of 7-substituted-3- quinolinecarbonitriles
SG144160A1 (en) 2003-07-24 2008-07-29 Bracco Imaging Spa Stable radiopharmaceutical compositions and methods for their preparation
ES2481402T3 (es) 2005-07-21 2014-07-30 Ardea Biosciences, Inc. Inhibidores de N-(arilamino)sulfonamida de MEK
WO2008009444A1 (en) * 2006-07-19 2008-01-24 Van Dulmen, Adrianus, A. Use of ethanol for stabilizing a single-vial liquid formulation of a radiolabeled peptide
CA3042737A1 (en) * 2016-11-04 2018-05-11 Clarity Pharmaceuticals Pty Ltd Formulations for radiotherapy and diagnostic imaging
US10596276B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions

Also Published As

Publication number Publication date
AU2025204901B2 (en) 2025-09-18
KR20210035855A (ko) 2021-04-01
EP4545101A2 (en) 2025-04-30
AU2022203683A1 (en) 2022-06-16
DK3826686T3 (da) 2025-08-25
EP4541381A3 (en) 2025-07-23
SI3826686T1 (sl) 2025-09-30
KR102643582B1 (ko) 2024-03-05
CO2021000506A2 (es) 2021-04-19
JP2025111424A (ja) 2025-07-30
IL319541B1 (en) 2025-09-01
JP2022501313A (ja) 2022-01-06
JP2023117417A (ja) 2023-08-23
MX2021000805A (es) 2021-05-12
AU2018433575A1 (en) 2021-02-11
CA3153630A1 (en) 2020-01-30
KR20250017751A (ko) 2025-02-04
KR102865113B1 (ko) 2025-09-26
SG11202100645XA (en) 2021-02-25
EP4541380A3 (en) 2025-07-23
AU2024201217A1 (en) 2024-03-14
EP4545101A3 (en) 2025-07-23
AU2018433575B2 (en) 2022-07-07
DE202018006567U1 (de) 2021-02-22
WO2020021322A1 (en) 2020-01-30
EP4545100A2 (en) 2025-04-30
IL280314A (en) 2021-03-25
FI3826686T3 (fi) 2025-08-20
IL313560B1 (en) 2025-07-01
BR112021001148A2 (pt) 2021-04-20
AU2025220852A1 (en) 2025-09-11
KR20240033296A (ko) 2024-03-12
IL313560A (en) 2024-08-01
AU2024201217B2 (en) 2025-02-27
IL319541A (en) 2025-05-01
EP4541381A2 (en) 2025-04-23
HRP20250912T1 (hr) 2025-09-26
EP4541380A2 (en) 2025-04-23
AU2025202231A1 (en) 2025-04-17
PL3826686T3 (pl) 2025-09-22
AU2022203683B2 (en) 2023-12-21
JP7402218B2 (ja) 2023-12-20
RS67034B1 (sr) 2025-08-29
EP3826686A1 (en) 2021-06-02
EP4545100A3 (en) 2025-07-23
IL319542A (en) 2025-05-01
EP3826686B1 (en) 2025-05-21
CN112584875A (zh) 2021-03-30
EP4541379A2 (en) 2025-04-23
AU2025204901A1 (en) 2025-07-17
EP4541379A3 (en) 2025-07-23
LT3826686T (lt) 2025-08-25

Similar Documents

Publication Publication Date Title
CA185390S (en) Stroller
IL319541B1 (en) Stable and concentrated radionuclide complex solutions
GB201916874D0 (en) .
IL291315A (en) A stable and concentrated radiopharmaceutical preparation
GB2575542B (en) Stroller
GB201913519D0 (en) Multi-zone, single trip completion system
ZA201705301B (en) Radiopharmaceutical solutions with advantageous properties
AU201717173S (en) Stroller
PL3231417T3 (pl) Odporna na składowanie kompozycja oftalmiczna
GB201808141D0 (en) Stroller
HK40119655A (en) Stable, concentrated radionuclide complex solutions
HK40119658A (en) Stable, concentrated radionuclide complex solutions
HK40119657A (en) Stable, concentrated radionuclide complex solutions
HK40119656A (en) Stable, concentrated radionuclide complex solutions
HK40119654A (en) Stable, concentrated radionuclide complex solutions
GB201917115D0 (en) .
GB201916765D0 (en) .
GB201715900D0 (en) Palate-transducers & palate-loudspeakers, new drawings
CA185051S (en) Bicycle
AU201815032S (en) Stroller
AU201815033S (en) Stroller
杨乐 Are you ready... Go
AU201811518S (en) Stroller
PH32018050263S1 (en) Bicycle
GB201807288D0 (en) Concentrated trombe-walled thermosyphon
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载